N1VS34 bonds
Below is the list of NOVARTIS AG DRN corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | — | 712 K | 96.46% | 4.20% | 2034-09-18 | 1.1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | — | 931 K | 81.37% | 3.70% | 2042-09-21 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | — | 9.12 M | 99.24% | 4.00% | 2031-09-18 | 850 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | — | 1.07 M | 89.53% | 4.70% | 2054-09-18 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | — | 68 K | 99.66% | 3.80% | 2029-09-18 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
— | 0 | 105.17% | 1.65% | 2031-06-18 | 435 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | — | 122 K | 97.47% | 2.00% | 2027-02-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 | — | 0 | 82.05% | 4.00% | 2045-11-20 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 | — | 0 | 99.55% | 3.00% | 2025-11-20 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNOJANOVARTIS FIN. 17/27 | — | 0 | 97.61% | 1.13% | 2027-09-30 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
— | 0 | 106.81% | 1.75% | 2034-06-16 | 645 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
— | 0 | 100.08% | 0.63% | 2029-11-13 | 550 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
— | 0 | 110.07% | 1.85% | 2049-06-18 | 190 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
— | 0 | 102.28% | 1.60% | 2027-06-18 | 650 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
UUS66989HAH1NOVARTIS CAPITAL 14/44 | — | 0 | 88.96% | 4.40% | 2044-05-06 | 1.85 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 | — | 0 | 81.86% | 1.70% | 2038-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
UUS66989HAS7NOVARTIS CAP 20/50 | — | 0 | 63.09% | 2.75% | 2050-08-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXS149282548NOVARTIS FIN. 16/28 | — | 0 | 94.70% | 0.63% | 2028-09-20 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
— | 0 | 100.17% | 1.05% | 2035-05-11 | 325 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
— | 0 | 107.80% | 1.85% | 2040-06-18 | 280 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG | |
UUS66989HAR9NOVARTIS CAP 20/30 | — | 0 | 91.14% | 2.20% | 2030-08-14 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 | — | 0 | 98.68% | 3.10% | 2027-05-17 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXS113472979NOVARTIS FIN. 14/26 | — | 0 | 99.24% | 1.63% | 2026-11-09 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS176904119NOVARTIS FIN. 18/30 | — | 0 | 93.73% | 1.38% | 2030-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 | — | 0 | 92.79% | 0.00% | 2028-09-23 | 1.85 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |